טוען...
Assessing quality of life in Alzheimer's disease: Implications for clinical trials
INTRODUCTION: Characterization of the quality of life (QOL) in Alzheimer's disease (AD) scale within the context of a clinical trial may inform its applicability in future trials. METHODS: Using data from 1322 patients enrolled in two phase-III studies (EXPEDITION 1 [NCT00905372] and 2 [NCT0090...
שמור ב:
| הוצא לאור ב: | Alzheimers Dement (Amst) |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312555/ https://ncbi.nlm.nih.gov/pubmed/28229126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.11.004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|